Induction of Differentiation of HL-60 Cells Along the Monocytic Pathway by 5-Methyltetrahydrofolate

References

• Bloch A. Induced cell differentiation in cancer therapy. Cancer Treat Rep 1984; 68: 199–205.
   Google Scholar
• Koeffler HP. Induction of differentiation of humanacute myelogenous leukemia cells: therapeutic implications. Blood 1983; 62: 709–721.
   Google Scholar
• Olofsson T, Olsson I. Suppression of normal granulopoiesis in vitro by a leukemia associated inhibitor (LAI) of acute and chronic leukemia. Blood 1980; 55: 975–982.
   Google Scholar
• Broxmeyer HE, Bognacki J, Dorner MH, De Sousa M. Identification of leukemia-associated inhibitory activity as acidic isoferritins. (A regulatory role for acidic isoferritins in the production of granulocytes and macrophages). J Exp Med 1981; 153: 1426–1444.
   Google Scholar
• Koeffler HP. Human acute myeloid leukemia lines: models of leukemogenesis. Sem Hematol 1986; 23: 223–236.
   Google Scholar
• Collins SJ, Gallo RC, Gallagher RE. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 1977; 270: 347–349.
   Google Scholar
• Rovera G, O’Breine TA, Diamond L. Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science 1979; 204: 868–871.
   Google Scholar
• Rovera G, Santoli D, Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA 1979; 76: 2779–2783.
   Google Scholar
• Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar com pounds. Proc Natl Acad Sci USA 1978; 75: 2458–2462.
   Google Scholar
• Sartorelli AC. Malignant cell differentiation as a poten tial therapeutic approach. Br J Cancer 1985; 52: 293–302.
   Google Scholar
• Kaplinsky C, Estrov Z, Freedman MH, Gelfand EW, Cohen A. Effect of deferoxamine on DNA synthesis, DNA repair, cell proliferation and differentiation of HL-60 cells. Leukemia 1987; 1: 437–441.
   Google Scholar
• Breitmann TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 2936–2940.
   Google Scholar
• Mangelsdorf DJ, Koeffler HP, Donaldson CA, Pike JW, Haussier MR. 1,25 dihydroxy-vitamin D3 induced differentiation in a human promyelocytic cell line (HL-60): receptor mediated maturation to macrophage-like cells. J Cell Biol 1984; 98: 391–398.
   Google Scholar
• Ball ED, Guyre PM, Shen L, Glynn JM, Maliszewski CR, Baker PE, Fanger MW. Gamma interferon induces monocytoid differentiation in the HL-60 cell line. J Clin Invest 1984; 73: 1072–1077.
   Google Scholar
• Olsson I, Olofsson T, Mauritzon N. Characterization of mononuclear blood cell derived differentiation inducing factors (DIFs) for the human promyelocytic leukemia cell line HL-60. J Natl Cancer Inst 1981; 67: 1225–1230.
   Google Scholar
• Olsson IL, Sarngadharan MG, Breitmann TR, Gallo RC. Isolation and characterization of a T lymphocyte derived differentiation inducing factor for myeloid leukemic cell line HL-60. Blood 1984; 63: 510–517.
   Google Scholar
• Nojiri H, Takaku F, Terui Y, Miura Y, Saito M. Ganglioside GM3: an acidic membrane component that increase during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U-937. Proc Natl Acad Sci USA 1986; 83: 782–786.
   Google Scholar
• Feuerstein N, Cooper HL. Studies of the differentiation of promyelocytic cells by phorbol ester. II: methylation inhibitor 3-deaza-adenosine inhibits the induction of specific differentiation proteins. Lack of the effect on early and late phosphorylation events. Biochem Biophys Acta 1984; 781: 247–256.
   Google Scholar
• Ziboh VA, Wong T. Induced rapid phospholipid methylation and arachidonic acid release by dimethyl sulfoxidetreated human promyelocytic leukemic HL-60 cells. Biochem Biophys Res Commun 1986; 140: 515–522.
   Google Scholar
• Anderson NL, Gemmell MA. Protein-pattern changes and morphological effects due to methionine starvation or treatment with 5-azacytidine of the phorbol-ester-sensitive cell lines HL-60, CCL119, and U-937. Clin Chem 1984; 30: 1956–1964.
   Google Scholar
• Creusot F, Acs G, Christmas JK. Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2’-deoxycytidine. J Biol Chem 1982; 257: 2041–2048.
   Google Scholar
• Pinto A, Attadia V, Fusco A, Ferrara R, Spada OA, Di Fiore PP. 5-A2a-2’-deoxycytidine induces terminal differen tiation of leukemic blasts from patients with acute myeloid leukemias. Blood 1984; 64: 922–929.
   Google Scholar
• Yam LT, Li CY, Crosby WH. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 1971; 55: 238–290.
   Google Scholar
• Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentia tion by dimethyl sulfoxide. J Exp Med 1979; 149: 969–974.
   Google Scholar
• Janossy G. Membrane markers in leukemia. In: Catovsky D, ed. The leukemic cell. New York: Churchill Livingstone, 1981: 129–183.
   Google Scholar
• Housset M, Daniel MT, Degos L. Small doses of ara-C in the treatment of acute myelogenous leukemia: differentiation of leukemic cells? Brit J Haematol 1982; 51: 125–129.
   Google Scholar
• Gold E, Mertelsmann K, Itri L, Gee T, Clarkson B, Moore M. Phase I clinical trial of 13-cis retinoic acid in myelodysplastic syndromes. Cancer Treat Rep 1984; 67: 981–986.
   Google Scholar
• Koeffler HP, Hirji K, Itri L. 1,25-dihydroxyvitamin D3: in vitro and in vivo effects on human preleukemic and leukemic cells. Cancer Treat Rep 1985; 69: 1399–1407.
   Google Scholar
• Hagenbeek A, Sizoo W, Lowenberg B. Treatment of acute myelocytic leukemia with low dose cytosine arabinoside: results of a pilot study in four patients. Leuk Res 1983; 7: 443–446.
   Google Scholar
• Koeffler HP. Myelodysplastic syndromes (preleuke mia). Sem Hematol 1986; 23: 284–299.
   Google Scholar
• Zelenka PS, Beebe DC, Feagans DE. Transmethylation of phosphatidylethanolamine: an initial event in embryonic chicken lens fiber cell differentiation. Science 1982; 217: 1265–1267.
   Google Scholar
• White JC. Bailey BD, Goldman ID. Lack of stereospecificity at carbon 6 of methyltetrahydrofolate transport in Ehrlich ascites tumor cells. J Biol Chem 1978; 253: 242–245.
   Google Scholar
• Sirotnak FM, Chello PL, Moccio DM, Kisliuk RL, Combepine G, Gaumont Y, Montgomery JA. Further studies on stereospecificity at carbon 6 for membrane transport of tetrahydrofolates. Diastereoisomers of 5-methyl-tetrahydrofolate as competitive inhibitors of transport of methotrexate in L1210 cells. Biochem Pharmacol 1979; 28: 2993–2997.
   Google Scholar
• Bodner AJ, Ting RC, Gallo RC. Induction of differen tiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. J Natl Cancer Inst 1981; 67: 1025–1030.
   Google Scholar
• Sokoloski JA, Beardsley GP, Sartorelli AC. Mechanism of induction of HL-60 leukemia cell differentiation by antifolates. Proc. Am. Ass. Cancer Res. 1989; 30: 479.
   Google Scholar
• Yen A, Freeman L, Fishbaugh J. Hydroxyurea induces precommitment during retinoic induced HL-60 terminal myeloid differentiation: possible involvement of gene amplification. Leuk Res 1987; 11: 63–71.
   Google Scholar
• Ishikura H. Okazaki T, Mochizuki T et al. Effects of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1,25-dihy droxyvitamin D3. Exp Hematol 1985; 13: 981–988.
   Google Scholar